添加微信 添加微信
添加微信
首页: 全球医药政策

加拿大-Bri Biopharmaceutical Research

时间:2021-10-21 12:09:54 来源:康安医药咨询 作者:康安医药咨询

BRI Biopharmaceutical Research Inc. is a specialized analytical, bioanalytical and DM/PK contract research organization (CRO) servicing pharmaceutical and biotechnology companies in discovery, preclinical and clinical programs supporting IND and NDA-enabling studies.BRI is a contract research organization (CRO) supporting pharmaceutical and biotechnology companies with their discovery, preclinical, and clinical drug development programs. BRI is accredited by Standard Council of Canada for its GLP compliance. Its successful track record in providing accurate and quality data in conformance with GLP, GCP and cGMP regulations within USFDA, OECD and MHLW (Japan) ensures that you achieve your development goals.

Phone: 604-432-9237 Fax: 604-432-9239
Web: http://www.bripharm.com
Add:101 – 8898 Heather Street,Vancouver, BC,V6P 3S8

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章